Contract manufacturer Capsugel signed a deal to buy a pair of smaller rivals in an effort to expand its capabilities in drug production. The company is paying an undisclosed sum for Xcelience and Powdersize, two firms that specialize in commercial manufacturing, packaging and labeling. More
> Martin Shkreli, the controversial CEO of Turing Pharmaceuticals and KaloBios ($KBIO), has been arrested on charges of securities fraud. News
> WuXi PharmaTech is selling a biologics plant to AstraZeneca ($AZN) for $100 million. Story
